gut microbiota

Mixture of milk sugars and live bacteria may restore damaged gut microbiotas

The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.

Dietary intervention may change the microbiota, alleviate fatty liver disease

The findings of a recent study suggest that resistant-starch supplements can alter the gut microbiota in ways that alleviate NAFLD.

How physical activities shape our gut microbiome

Silvia Barbaresi, molecular biologist, researcher and nutritionist at Ghent Univerity, discusses how sports and physical activity in general impact on gut microbiota composition.

Socio-economic adversities are associated with gut microbiota alterations

Microbial differences may help to identify targets that could be modulated to mitigate health inequities.

The impact of gut bacteria on micronutrient status in the host

The interplay between micronutrients and the microbiome is a significant factor in determining the risk of vitamin and mineral deficiencies, which has implications for global public health.

Unraveling the gut microbiome’s role in celiac disease pathogenesis

Alessio Fasano, pediatric gastroenterologist and researcher at Harvard Medical School, discusses how celiac disease could become a model to study the link between gut microbiome and disease pathogenesis.

How Akkermansia and Lactobacillus plantarum could revolutionize treatment for Lupus through immune regulation

This study demonstrated fundamental mechanisms through which A. muciniphila and L. plantarum modify the gut microbiota and control immune responses in the SLE mouse model.

The cutting-edge potential of Microbial Therapeutics in microbiome modulation

Gianluca Ianiro, from Gemelli Hospital in Rome, discusses the future of microbiota modulation, with a focus on Microbial Therapeutics.

Probiotics and clinical practice

Francisco Guarner, from Centro Médico Teknon (Barcelona, Spain), talks about the recent update of the WGO’s Probiotics and prebiotics guidelines.

New compound offers hope for treating inflammatory bowel diseases

The findings of a recent study suggest that (S)-IBD3540 is a promising approach for treating IBD in people.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.